Académique Documents
Professionnel Documents
Culture Documents
What is ISBAR?
ISBAR is a structured communication tool that improves the quality of information exchange when discussing patients. The tool was
Carol Vance
Request / Recommendation
State what you want and ask questions. What you say for situation may be a concise summary of what you say for assessment and request. This repetition is helpful as it emphasises the key purpose of the referral.
continued from back page... Adverse reactions to chemotherapy (ADR) were common however few resulted in the delay of treatment. Only two patients required treatment cessation (Figure 3,4).
Pharmacy news
Treatment options for Gestational Trophoblastic Disease
Gestational trophoblastic disease (GTD) covers a spectrum of tumors ranging from premalignant (hydatidiform mole) to malignant (invasive mole or choriocarcinoma).
Huda Ismail
initially developed in the Navy to improve communication and has since been adapted for medical use. Inefficient communication can compromise patient care and using a standard approach to communication decreases the chance of forgetting relevant information and helps to decrease assumptions by making the reason for the call obvious at the outset. I Identification S Situation B Background
1 2 3
Claire Fitzgerald
1 Nil ADR. 28 (74%) 2 ADR result in hospital admission. 3 (8%) 3 ADR result in treatment cessation. 2 (5%) 4 ADR managed with medications. 5 (13%)
These proliferate to form abnormal trophoblasts. The uterus enlarges rapidly despite the absence of a fetus and the placenta contains many cysts to give a typical molar appearance. Maternal blood vessel formation increases and facilitates metastatic spread of the disease. Human chorionic gonadotrophin (hCG) is synthesised in the molar tissues and therefore can be used as a tumour marker to monitor disease progression or response. Invasive moles, choriocarcinomas and placental site trophoblasts are malignant tumours and are collectively known as gestational trophoblastic tumours1. GTDs are classified as low risk,
Ultra-high risk patients are treated with the EMAPE regimen which includes Etoposide, high dose Methotrexate and Actinomycin, given on alternate weeks with CisPlatin and Etoposide with or without intrathecal methotrexate. All patients diagnosed with molar pregnancy are recorded in the Hydatidiform Mole Registry. Between 2002 and 2008, a total of 649 patients were diagnosed with molar pregnancy. Only forty-eight (7%) patients had persistent elevated hCG and received medical treatment (Figure 2). Thirty eight of those patients received low risk treatment seven of them developed resistance to Methotrexate and were switched on to the high risk treatment regimen. In total ten patients received high risk treatment and only one patient received the ultrahigh risk regimen.
1 Low risk managed with MTX. 31 (66%) 2 Low risk resistent to MTX. 7 (1%) 3 Transferred to other hospital. 4 (8%) 4 Currently receiving treatment. 1 (2%) 5 Ultra-high risk. 1 (2%) 6 High risk treatment required. 1 (2%)
Complete and partial hydatidiform moles are the two most common types of pre-malignant GTD and both can progress to invasive moles. In a complete mole, an ovum devoid of maternal nuclear DNA is fertilised by 2 sperm or a single sperm it duplicates its chromosomes
EDITORIAL
The backbone of good (best) clinical practice remains patient centred care that is effective and safe. This edition has articles that address the last two of these. Most clinicians consider identifying their patient as a given. So routine that there can be a lapse in concentration. Readers will be astonished to hear that in recent years there have been 105 incidents reported at the Womens where there has been such a lapse. As Ruth Bergman points out in her article on page 4 the true incidence of misidentifying patients is not known. Another patient safety article concerns the age old issue of washing our hands to reduce nosocomial infection. Andrew Daley reports that the gap between doctors and nurses in handwashing compliance has widened again. In August 2008 it was nurses 73%, doctors 67% whereas in August 2009 it was 79% versus 51%! With regards to effective care, Huda Ismail reviews the management of trophoblastic disease in the Pharmacy section, and Jenny Taylor reviews the use of vitamin supplements in our pregnant patients. Her audit shows that pregnant women with poor diets who could benefit most from multivitamin supplements were the least likely to use them. Sobering stuff. Finally, many around the hospital will now be aware of the ISBAR tool for effective communication. Carol Vances and Claire Fitzgeralds article is a concise reminder of the methodology. Please let us know what you think, both of our content this year and thoughts for future articles.
Leslie Reti, editor Leslie.reti@thewomens.org.au
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
Nil ADR ADR managed ADR result with medication in dose change or treatment delay ADR result in hospital admission
to give a diploid complement of male DNA. In a partial mole the two sperms fertilise an ovum with maternal nuclear DNA forming a triploid conceptus (Figure 1).
Normal conception A single sperm with 23 chromosomes fertilises an egg with 23 chromosomes Partial Mole Two sperm fertilise an egg. This results in a triploid conceptus with 69 chromosomes. Monospermic Complete Mole This results in a conceptus with 46 chromosomes but all of them are derived from the father.
Identify
Identify yourself, the person you are speaking to, the patient, your location.
ADR were similar in both main regimen as shown in Figure 5 Chemotherapy is an effective treatment for GTD. Resistance to methotrexate has been low and is effectively managed with other chemotherapy agents.
EMACO group MTX group
high risk and ultrahigh risk and their medical management differs based on the risk and resistance to chemotherapy. Low risk patients are managed with the methotrexate (MTX) and calcium folinate regimen. Actinomycin may be used as an alternative if methotrexate is not tolerated. High risk patients are managed
Situation
Spoil the story. Stating the purpose of the call at the start of the conversation helps the receiver focus their attention appropriately when listening to the story. If urgent, make this clear from the start.
con
hea
dro
mo
Background
Tell the story. Provide relevant information only and remember, less is more, particularly if the receiver already knows the patient.
9 8 7 6 5 4 3 2 1 0
er n pain he B sea eye ia igu S n atio ctio SO ulc em dr y n au fat d ac ras NP h e infe ana stip uth p in
and
43 5
This results in a conceptus with 46 chromosomes but again all of them are derived from the father.
with the EMACO regimen, which consists of Etoposide, Methotrexate and Actinomycin, given on alternate weeks with Cyclophosphamide and vincristine(Oncovin).
Assessment
State what you think is going on. Give your interpretation of the situation. Include your degree of certainty - stating the obvious is helpful. Dont leave the receiver to guess what you are thinking tell them.
References
1. Gestational Trophoblastic disease, SOGC Clinical Practice Guidelines, No. 114, May 2002
For any further enquiries regarding Pharmacy news please contact rwh.pharmacy@thewomens.org.au
Please let the associate editors have your Please let the associate editor have your views on the views on the contents of this newsletter, or contents of this newsletter, or any other matters involving any other matters involving clinical practice clinical practice which may be of interest to our readers. which may be of interest to our readers. 5
Susan Braybrook, telephone (03) 8345 2025 or email susan.braybrook@thewomens.org.au For further information http://www.thewomens.org.au For intranet users http://intranet.thewomens.org.au/qualityandsafety
HeraldSun 25.5.08
continued from page 2... This was a snapshot of what the of many pregnant women. 33% of the women surveyed were getting supplemental iodine either from multivitamins or iodized salt 77% of the women took folic acid supplements at some stage during the pregnancy (alone or in multivitamin or iron preparations), however only 29% started it before conception. Most of the remaining 48% commenced after they knew they were pregnant and thought this was appropriate. 43% had indicators of iron deficiency sometime during the pregnancy to date. At the time of the audit only 46% of iron deficient women were taking iron supplements in doses large enough to be likely to correct deficiency i.e. 60mg or more per day. 69% of the women had test results available for vitamin D. 48% of this sample were deficient when first tested, with 69% of deficient women on supplements of 1000 IU or more. Iron, iodine, calcium and folic acid were common dietary deficiencies. Women with biochemistry indicating iron or Vitamin B12 deficiency were twice as likely to have inadequate diets (by dietary recall) and were also less likely to be taking multivitamins. In contrast women with adequate diets were twice as likely to use multivitamin supplements as those with inadequate diets.
RWH
Nov 2007 Mar 2008 Aug 2008 Nov 2008 Mar 2009 Aug 2009 44% 48% 67% 73% 73% 61% 77% 80% 50% 73% 78% 51% 75% 79% 21%
women were doing at the time they were seen. They may have been at any stage in the pregnancy but second trimester was the most common time.
pregnant women with poor diets who could benefit most from multivitamin supplements were the least likely to use them
In conclusion pregnant women with poor diets who could benefit most from multivitamin supplements were the least likely to use them. multivitamin supplement users may still miss out on at risk nutrients. There is no single supplement that contains iron (in significant amounts) as well as folic acid and iodine. most women were unaware that folic acid needs to be started before pregnancy many iron- or Vitamin D deficient women were not taking supplements. Whether this was due to non-prescription or non compliance was not assessed.
Jenny Taylor Department of Nutrition and Dietetics, The Royal Womens Hospital jenny.taylor@thewomens.org.au
Results
Supplement use was common with 55% of the women taking multivitamin preparations. Elevit was the most popular, used by 47% of those taking a multivitamin supplement, followed by Blackmores Pregnancy and Breastfeeding Gold at 33%. The remaining 20% were taking a variety of at least 9 other brands.
3. Perform the Hand Hygiene competency quiz (takes 5 minutes) at http://intranet.thewomens. org.au/ClinicalEducation Competency Assessment 4. Play the Wi 5 game: http:// www.rch.org.au/washup/prof.cfm? doc_id=12968 5. Model appropriate practices for more junior staff and medical students. 6. Work with senior nursing staff to assist with enforcing HH compliance. 7. Review the WashUp website at www.washup.org.au
Supplement use was common with 55% of the women taking multivitamin preparations
Supplements vary in content of significant nutrients such as iron, vitamin D, omega 3 and vitamin B12. One of the reasons Elevit is popular is because it contains a substantial iron dose, however in contrast to other pregnancy multivitamins, it contains no iodine (at this stage). Iodine is one of the nutrients most needed from a supplement as there is mild deficiency in most parts of Australia. Even bread fortification (commencing September 2009) will not meet the iodine needs
from 2005 the Quality and Safety unit at The Womens has received 105 reports of patient safety incidents associated with the wrong identification of a woman or baby
This information is checked for accuracy against the consent or procedural request form and appropriate diagnostic images (when available). In theatre this process is called Team Time Out where a standard formal process is followed by the whole team; the anaesthetist, surgeon and theatre nurses. The matching of the correct person, procedure, site and side occurs at all stages of outpatient and inpatient contact. That is, when a procedure is booked; at the time of admission; during preparation for a procedure; upon admission to a department where the procedure is to be conducted (e.g. Pauline Gandel Womens Imaging Centre, Day Chemotherapy, Pregnancy Day Care Centre) and again on entry to the procedural room and indeed anytime a woman or baby moves within the hospital or is transferred to another hospital location.
Ruth Bergman Clinical Incident Co-Ordinator
usual dietary intake nutritional supplement use both self prescribed and prescribed by health professionals biochemistry that could indicate nutritional deficiency such as iron deficiency indicators, Vitamin B12 and folate levels, using Clara or laboratory results filed in patients records. This was not a random sample as the women had been referred to dieticians for reasons such as weight control or diabetes or were screened because they were attending higher risk antenatal clinics such as Multiple Pregnancy, WADs or Young Womens Clinic.
Natures Way Pregnancy Smart Swisse Pregcel Natal Plus Natures Own Pregnancy Platinum
10
500
300
to check how supplement use related to womans individual needs as well as to nutrients that are at risk in pregnant women in general such as iron, folic acid and iodine. 218 pregnant outpatients routinely seen by dieticians at RWH had assessment of 2
References
1. RISKMAN incident database, report by patient identification classification 2. Australian Commission on Safety and Quality in Health Care 2009 Identification of Adults; Identification of Babies Womens Hospital Procedure located on the Intranet.
*Recommended dietary intake for healthy women. Recommendations may be different if deficiency is present